For Research Use Only — Not for Human Consumption
The 2x Blend combines CJC-1295 No DAC (a GHRH analogue) and Ipamorelin (a GHSR agonist). Research focuses on the synergistic mechanism of these two peptides, exploring how their combined application amplifies pulsatile somatotropic cellular responses in various in-vitro and animal models.
Create a free researcher account to view pricing and order.
Batch #23CJCIPA-0226 | HPLC & MS Analysis Verified
The 2x Blend is a specialized research formulation combining two distinct peptides: CJC-1295 No DAC (also known as Mod GRF 1-29) and Ipamorelin. CJC-1295 No DAC acts as a Growth Hormone-Releasing Hormone (GHRH) analogue, while Ipamorelin functions as a selective Growth Hormone Secretagogue Receptor (GHSR) agonist.
Current laboratory and in-vitro applications focus on the synergistic physiological response generated by combining a GHRH analogue with a secretagogue. Researchers utilize this 2x Blend to observe how activating two separate cellular pathways simultaneously can yield a magnified, pulsatile response from somatotropic cells without significantly elevating cortisol or prolactin levels. This dual-action mechanism makes the blend highly relevant for advanced research into cellular metabolism, muscular hypertrophy pathways, and sophisticated anti-aging cellular repair models.
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.
Ipamorelin, the first selective growth hormone secretagogue.
Growth hormone-releasing hormone (GHRH) and GHRH secretagogues.
But you do not meet the requirements to access this website.
18 years of age or older,
Qualified researchers or professionals
This website contains research chemicals intended strictly for laboratory and research use only. You must be 18 years of age or older to enter. By clicking I AGREE you confirm that you are 18+ years of age, a qualified researcher, and understand these products are not for human consumption.